These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
70. Prevalence of Monogenic Causes in Pediatric Patients with Nephrolithiasis or Nephrocalcinosis. Braun DA; Lawson JA; Gee HY; Halbritter J; Shril S; Tan W; Stein D; Wassner AJ; Ferguson MA; Gucev Z; Fisher B; Spaneas L; Varner J; Sayer JA; Milosevic D; Baum M; Tasic V; Hildebrandt F Clin J Am Soc Nephrol; 2016 Apr; 11(4):664-72. PubMed ID: 26787776 [TBL] [Abstract][Full Text] [Related]
71. No stone unturned: The epidemiology and outcomes of paediatric urolithiasis in Manchester, United Kingdom. Robinson C; Shenoy M; Hennayake S J Pediatr Urol; 2020 Jun; 16(3):372.e1-372.e7. PubMed ID: 32249190 [TBL] [Abstract][Full Text] [Related]
72. [Characteristics of genotype of monogenic nephrolithiasis in Chinese pediatric patients with nephrolithiasis]. Ge YC; Zhan RC; Wang L; Ning C; Du Y; Li J; Tian Y; Wang WY Zhonghua Yi Xue Za Zhi; 2021 Oct; 101(38):3115-3120. PubMed ID: 34674420 [No Abstract] [Full Text] [Related]
73. Hypercalciuria and nephrolithiasis: Expanding the renal phenotype of Donnai-Barrow syndrome. Anglani F; Terrin L; Brugnara M; Battista M; Cantaluppi V; Ceol M; Bertoldi L; Valle G; Joy MP; Pober BR; Longoni M Clin Genet; 2018 Jul; 94(1):187-188. PubMed ID: 29532936 [TBL] [Abstract][Full Text] [Related]
74. Metaphylaxis of nephrolithiasis. Jacobellis U Urol Int; 2007; 79 Suppl 1():51-5. PubMed ID: 17726353 [TBL] [Abstract][Full Text] [Related]
75. Nephrolithiasis in Israel: Epidemiological Characteristics of Return Patients in a Tertiary Care Center. Abu-Ghanem Y; Kleinmann N; Winkler HZ; Zilberman DE Isr Med Assoc J; 2016 Dec; 18(12):725-728. PubMed ID: 28457074 [TBL] [Abstract][Full Text] [Related]
76. [Metabolic changes in 2612 patients with nephrolithiasis]. del Valle E; Spivacow R; Zanchetta JR Medicina (B Aires); 1999; 59(5 Pt 1):417-22. PubMed ID: 10684159 [TBL] [Abstract][Full Text] [Related]
77. Pediatric urolithiasis--evaluation of risk factors in 95 children. Erbagci A; Erbagci AB; Yilmaz M; Yagci F; Tarakcioglu M; Yurtseven C; Koyluoglu O; Sarica K Scand J Urol Nephrol; 2003; 37(2):129-33. PubMed ID: 12745721 [TBL] [Abstract][Full Text] [Related]
78. [A complicated case of calcium urolithiasis in a carrier of SLC7A9 gene mutation responsible for cystinuria]. Litvinova MM; Filippova TV; Khafizov KF; Svetlichnaya DV; Ahmedzyanova DA; Rudenko VI; Gadzhieva ZK; Shumikhina MV Urologiia; 2020 Dec; (6):126-130. PubMed ID: 33377691 [TBL] [Abstract][Full Text] [Related]
79. Results of medical treatment and metabolic risk factors in children with urolithiasis. Gürgöze MK; Sarı MY Pediatr Nephrol; 2011 Jun; 26(6):933-7. PubMed ID: 21340610 [TBL] [Abstract][Full Text] [Related]